期刊文献+

超排卵中血清孕酮升高 被引量:6

Progesterone elevation occurred in controlled ovarian stimulation
下载PDF
导出
摘要 控制性卵巢刺激(COS)中,可以观察到晚卵泡期孕激素升高(PE)的现象。卵泡刺激素(FSH)和黄体生成素(LH)作用于颗粒细胞,促使胆固醇转化为孕酮(P),卵泡膜细胞也能产生足够数量的P。P在卵泡膜细胞内的LH作用下进一步转化为雄激素,孕酮产生的来源过多或者无法及时代谢都会造成循环中的P升高,进而降低子宫内膜容受性,影响体外受精-胚胎移植(IVF-ET)的结局。P水平与成熟卵泡数目、雌激素水平、FSH总剂量正相关,LH过高或过低都促使P升高。与拮抗剂方案相比,降调节超排卵并不增加P升高的几率。选用温和的COS方案、减少FSH剂量、调整外源性FSH/HMG的用药比例、提前HCG诱发排卵时间、全胚冷冻后解冻移植、囊胚移植等方法可以避免P升高导致的不利影响。 Moderate elevations in serum progesterone(P)levels are observed during ovarian stimulation(COS).FSH and LH act on granulosa cells,promoting cell division and steroid biosynthesis from cholesterol terminating at progesterone biosynthesis.Thecal cells also produce significant amounts of progesterone.Progesterone is further metabolized to androgens by the thecal cells under the trophic influence of LH.Too much source of progesterone and failure metabolism timely causes progesterone elevation(PE).PE has negative impact on the IVF outcome by reducing endometrial receptivity.The progesterone levels are positively related to number of mature follicles,estradiol levels and total dose of FSH used.Too high and too low LH levels also promote progesterone elevation.Compared with GnRH antagonist protocol,PE does not easily occurred in down-regulation ovarian stimulation with GnRH agonist protocol.Moderate COS protocol,low dose FSH,adjustment proportion of FSH/HMG dosage,earlier administration of HCG,frozen-thawed embryo transfer,blastocyst embryo transfer can avoid negative effect of progesterone elevation.
出处 《生殖医学杂志》 CAS 2015年第10期811-815,共5页 Journal of Reproductive Medicine
关键词 孕酮升高 降调节 控制性卵巢刺激 Progesterone elevation Down-regulation Controlled ovarian stimulation
  • 相关文献

参考文献24

  • 1Fleming R. Progesterone elevation on the day of hCG ethodological issues [J]. Hum Rcprod Update, 2008, 14: 391-392.
  • 2Moon YS, Tsang BK, Simpson C, et al. 17Beta-estradio biosynthesis in cultured granulosa and theeal cells of human ovarian follicles: stimulation by follicle-stimulating hormone [J]. J Clin Endocrinol Metab, 1978,47 : 263-267.
  • 3Fleming R, Jenkins J. The source and implications of pogesterone rise during the follicular phase of assisted reproduction eyclesEJ/OL]. Reprod BioMed Online, 2010,21 = 446-449.
  • 4Haouzi D, Bissonnette L, Gala A, et al. Endometrial Receptivity Profile in Patients with Premature Progesterone Elevation on the Day of hCG AdministrationFJ:. Biomed Res Int,2014,11:1-10.
  • 5Hugues JN,Massfi-Laroehe E, Reboul-Marty J, et al. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionie gonadotropin administration EJ]. Fertil Steril, 2011, 96=600-604.
  • 6Orvieto R, Patrizio P. GnRH agonist versus GnRH antagonist in ovarian stimulation: an ongoing debate[J/OL:. Reprod Biomed Online, 2013,26 : 4-8.
  • 7Venetis CA, Kolibianakis EM, Bosdou KC, et al. Progesterone elevation and probability of pregnancy after IVF.-a systematic review and meta-analysis of over 60 000 cycles[J]. Hum Reprod Update, 2013,19 : 433 457.
  • 8Kolibianakis EM, Venetis CA, Bontis J, et al. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins:a systematic review and meta analysis [J]. Curr Pharm Biotechnol, 2012,13 : 464-470.
  • 9Bosch E, Labarta E, Crespo J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization; analysis of over 4000 eyeles[J]. Hum Reprod, 2010,25 .-2092-2100.
  • 10Kilicdag EB, Haydardedeoglu B, Cok T, et al. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles[J]. Arch Gynecol Obstet, 2010,281 : 747-752.

二级参考文献25

  • 1Perez MM, Gromoll J, Behre HM, et al. Ovarian response to follicle stimulating hormone(FSH) stimulation depends on the FSH receptor genotype[J]. J Clin Endoerinol Metab, 2000,85(9) :3365-3369.
  • 2LoretiN, Ambai V, Juliato CT, et al. Carbohydrate complexity and proportion of serum FSH isoforms reflect pituitary ovarian activity in perimenopausal women and depot medroxyprogesterone acetate users [ J ]. Clin Endocrinol, 2009,71(4):558-565.
  • 3Nahuis M, vander VF, Oosterhuis J, et al. Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women[J]. Int J Womens Health,2010,9(1) :205-211.
  • 4Virtu A, Nayudu PL, Roseu M, et al. Embryonic development after follicle culture is influenced by FSH pl range[J]. Biul Reprod,2001,65(5) :1542-1547.
  • 5West CR, Carlson NE, Lee JS, et al. Acidic mix of FSH isoforms are better facilitators of ovarian follicular maturation and Ez production than the less acidic[J]. Endocrinology, 2002,143(1):107-116.
  • 6Mohamed MA, Sbracia M, Pacchiarotti A, et al. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study[J]. Fertil Steril,2006, 85(5) : 1398-1403.
  • 7Selman HA, De Santo M, Sterzik K, et al. Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality[J]. Fertil Steril, 2002, 78(5),1061-1067.
  • 8Touraine P, Beau I, Gougeon A, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor, correlations between receptor function and phenotype[J]. Mol Endocrinol, 1999,13(11) : 1844-1855.
  • 9Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man[J]. J Clin Endocrinol Metab, 1996, 81(4) :1367-1370.
  • 10Beau I, Touraine P, Meduri G, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor[J]. J Clin Invest, 1998, 102 (7) : 1352-1359.

同被引文献37

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部